Global e∙dentity™ files separate actions for third-party review with the USPTO corresponding to Apple
WILMINGTON, Del., April 17, 2019 (GLOBE NEWSWIRE) -- On March 18 and again April 1, 2019, Global e∙dentity,™ a tech start-up with national security applications in mind founded by Robert Adams, a U.S. Navy veteran -- filed two different third-party review requests with the United States Patent and Trade Office in opposition to two recently published Apple patent applications 15/900,905 and 16/132,241 (USPTO third party filing is noted on the Global e∙dentity™ website: https://www.globaledentity.com/third-party-review-uspto/).
On November 20, 2018, after only 292 days, Global e∙dentity™ received its first patent 10,135,822 “Biometric authentication of individuals utilizing characteristics of bone or blood vessel structures” for its groundbreaking, multi-modal biometric identification technology. The patented technology can be built into a small electronic device like a phone, a watch, eyeglasses, door or just about anything and uses varying frequencies of near-infrared (a.k.a. light Transducer) to scan the vascular structure of any living human body part or non-human. Also, for added security, one can use varying frequencies of ultrasound or a scanning device to examine the underlying bone structure for additional biometrics that can include two proofs of life to identify any person resulting in a near-perfect identification match rate of 1 in 7.5 billion.
Co-founder and CFO, Edgar Rabano concluded: “Our team built and patented our invention(s) and its eight patent continuations; hence we will continue to protect our intellectual property portfolio and seek partnerships to grow the company.”
For more information, visit www.globaledentity.com. Global e·dentity™ and product are either registered trademarks or trademarks of You are the ID ™ LLC in the United States and/or other countries. For more information, press only: Sophia Miller sophiam@globaledentity.com
For details: www.globaledentity.com/patented-infrared-transducer-vascular-matching/
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
